| [1] |
Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy[J]. Eur Heart J, 2021, 42(35):3427-3520.
|
| [2] |
Indik JH, Gimbel JR, Abe H, et al. 2017 HRS Expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices[J]. Heart Rhythm, 2017, 14(7):e97-e153.
|
| [3] |
Stühlinger M, Burri H, Vernooy K, et al. EHRA Consensus on prevention and management of interference due to medical procedures in patients with cardiac implantable electronic devices[J]. Europace, 2022, 24(9):1512-1537.
|
| [4] |
褚松筠, 王玉玲, 蒋捷, 等. 起搏器患者进行磁共振检查的安全性研究[J].临床心血管病杂志, 2020, 36(11):1008-1012.
|
| [5] |
邢强, 祖克拉·吐尔洪, 张疆华, 等. 磁共振兼容起搏器行1.5 T磁共振扫描的安全性研究[J].中华心律失常学杂志,2021, 25(5):408-412.
|
| [6] |
武敏, 于海波, 梁延春, 等. 心脏起搏器植入患者进行核磁共振扫描安全性研究[J].临床军医杂志,2019, 47(2):153-155.
|
| [7] |
Roguin A, Zviman MM, Meininger GR, et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T[J]. Circulation, 2004, 110(5):475-482.
|
| [8] |
Nazarian S, Hansford R, Rahsepar AA, et al. Safety of magnetic resonance imaging in patients with cardiac devices[J]. N Engl J Med, 2017, 377(26):2555-2564.
|
| [9] |
Russo RJ, Costa HS, Silva PD, et al. Assessing the risks associated with mri in patients with a pacemaker or defibrillator[J]. N Engl J Med, 2017, 376(8):755-764.
|
| [10] |
Balmer C, Gass M, Dave H, et al. Magnetic resonance imaging of patients with epicardial leads: in vitro evaluation of temperature changes at the lead tip[J]. J Interv Card Electrophysiol, 2019, 56(3):321-326.
|
| [11] |
Mattei E, Gentili G, Censi F, et al. Impact of capped and uncapped abandoned leads on the heating of an MR-conditional pacemaker implant[J]. Magn Reson Med, 2015, 73(1):390-400.
|
| [12] |
Bhuva AN, Moralee R, Brunker T, et al. Evidence to support magnetic resonance conditional labelling of all pacemaker and defibrillator leads in patients with cardiac implantable electronic devices[J]. Eur Heart J, 2022, 43(26):2469-2478.
|
| [13] |
Schaller RD, Brunker T, Riley MP, et al. Magnetic resonance imaging in patients with cardiac implantable electronic devices with abandoned leads[J]. JAMA Cardiol, 2021, 6(5):549-556.
|
| [14] |
Greenhill MJ, Rangan P, Su W, et al. MRI in Patients with cardiovascular implantable electronic devices and fractured or abandoned leads[J]. Radiol Cardiothorac Imaging, 2024, 6(3):e230303.
|
| [15] |
Homsi R, Mellert F, Luechinger R, et al. Safety and feasibility of magnetic resonance imaging of the brain at 1.5 Tesla in patients with temporary transmyocardial pacing leads[J]. Thorac Cardiovasc Surg, 2019, 67(2):86-91.
|
| [16] |
Rahsepar AA, Zimmerman SL, Hansford R, et al. The relationship between mri radiofrequency energy and function of nonconditional implanted cardiac devices: a prospective evaluation[J]. Radiology, 2020, 295(2):307-313.
|
| [17] |
Mollerus M, Albin G, Lipinski M, et al. Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions[J]. Europace, 2010, 12(7):947-951.
|
| [18] |
Golestanirad L, Rahsepar AA, Kirsch JE, et al. Changes in the specific absorption rate (SAR) of radiofrequency energy in patients with retained cardiac leads during MRI at 1.5T and 3T[J]. Magn Reson Med, 2019, 81(1):653-669.
|
| [19] |
Bhuva A, Charles-Edwards G, Ashmore J, et al. Joint British Society consensus recommendations for magnetic resonance imaging for patients with cardiac implantable electronic devices[J]. Heart, 2024, 110(4):e3.
|
| [20] |
Munawar DA, Chan J, Emami M, et al. Magnetic resonance imaging in non-conditional pacemakers and implantable cardioverter-defibrillators: a systematic review and meta-analysis[J]. Europace, 2020, 22(2):288-298.
|
| [21] |
Shah AD, Morris MA, Hirsh DS, et al. Magnetic resonance imaging safety in nonconditional pacemaker and defibrillator recipients: a meta-analysis and systematic review[J]. Heart Rhythm, 2018, 15(7):1001-1008.
|
| [22] |
Kim D, Collins JD, White JA, et al. SCMR Expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device[J]. J Cardiovasc Magn Reson, 2024, 26(1):100995.
|
| [23] |
Vuorinen AM, Lehmonen L, Karvonen J, et al. Reducing cardiac implantable electronic device-induced artefacts in cardiac magnetic resonance imaging[J]. Eur Radiol, 2023, 33(2):1229-1242.
|
| [24] |
Schwitter J, Gold MR, Al Fagih A, et al. Image quality of cardiac magnetic resonance imaging in patients with an implantable cardioverter defibrillator system designed for the magnetic resonance imaging environment[J]. Circ Cardiovasc Imaging, 2016, 9(5):e004025.
|
| [25] |
Do DH, Eyvazian V, Bayoneta AJ, et al. Cardiac magnetic resonance imaging using wideband sequences in patients with nonconditional cardiac implanted electronic devices[J]. Heart Rhythm, 2018, 15(2):218-225.
|
| [26] |
Gimbel JR, Bello D, Schmitt M, et al. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla[J]. Heart Rhythm, 2013, 10(5):685-691.
|
| [27] |
Shenthar J, Milasinovic G, Al Fagih A, et al. MRI Scanning in patients with new and existing CapSureFix Novus 5076 pacemaker leads: randomized trial results[J]. Heart Rhythm, 2015, 12(4):759-765.
|
| [28] |
Awad K, Griffin J, Crawford TC, et al. Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions[J]. Heart Rhythm, 2015, 12(10):2155-2161.
|
| [29] |
Ching CK, Chakraborty RN, Kler TS, et al. Clinical safety and performance of a MRI conditional pacing system in patients undergoing cardiac MRI[J]. Pacing Clin Electrophysiol, 2017, 40(12):1389-1395.
|
| [30] |
Friedman HL, Acker N, Dalzell C, et al. Magnetic resonance imaging in patients with recently implanted pacemakers[J]. Pacing Clin Electrophysiol, 2013, 36(9):1090-1095.
|
| [31] |
Barreiro-Pérez M, Cabeza B, Calvo D, et al. Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document[J]. Rev Esp Cardiol (Engl Ed), 2023, 76(3):183-196.
|
| [32] |
Marczak M, Świerżyńska E, Śpiewak M, et al. Magnetic resonance imaging in patients with implanted cardiac electrotherapy devices: a statement from experts of the Polish Medical Society of Radiology, the Polish Society of Cardiology, and the Polish Society of Electroradiology[J]. Pol J Radiol, 2024, 89:e1-e5.
|
| [33] |
Minaskeian N, Hajnal SP, Liu MB, et al. Safety of magnetic resonance imaging in patients with cardiac implantable electronic devices with generator and lead(s) brand mismatch[J]. J Appl Clin Med Phys, 2022, 23(3):e13520.
|
| [34] |
Pitman BM, Ariyaratnam J, Williams K, et al. The burden of cardiac implantable electronic device checks in the peri-MRI setting: the CHECK-MRI study[J]. Heart Lung Circ, 2023, 32(2):252-260.
|
| [35] |
Cronin EM, Wilkoff BL. Magnetic resonance imaging conditional pacemakers: rationale, development and future directions[J]. Indian Pacing Electrophysiol J, 2012, 12(5):204-212.
|
| [36] |
Mullane S, Michaelis K, Henrikson C, et al. Utilization and programming of an automatic MRI recognition feature for cardiac rhythm management devices[J]. Heart Rhythm O2, 2021, 2(2):132-137.
|
| [37] |
Savouré A, Mechulan A, Burban M, et al. The Kora pacemaker is safe and effective for magnetic resonance imaging[J]. Clin Med Insights Cardiol, 2015, 9:85-90.
|
| [38] |
Thiyagarajah A, Strik M, Ploux S, et al. Contemporary management and programming of cardiac implantable electronic devices in patients undergoing magnetic resonance imaging[J]. Heart Rhythm, 2025: S1547-5271(25)03148-0.
|
| [39] |
Baroni M, Carbonaro M, Felisi M, et al. Simplifying MRI workflow for patients with cardiac implantable electronic devices: Technologies for automatic MRI mode switching[J]. Int J Cardiol, 2026, 444:134006.
|
| [40] |
中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会. 心血管植入型电子器械术后随访的专家共识(2020)[J].中华心律失常学杂志,2020, 24(6):532-544.
|